


































In live cells, DNA is continuously being damaged by 
reactive oxygen species (ROS), the by-products of 
aerobic respiration in mitochondria [1-6]. Exogenous 
oxidants originating from environmental pollutants [7],
 
phagocyte-oxidative burst [8-10], and even iatrogenic 
factors [11], additionally contribute to DNA damage. 
Such DNA damage involves oxidation of the 
constituent DNA bases, particularly of guanine by 
formation of 8-oxo-7,8-dihydro-2'-deoxyguanosine 
(oxo8dG), base ring fragmentation, modification of 
deoxyglucose, crosslinking of DNA and protein, and 
induction of DNA double strand breaks (DSBs) [12,13]. 
Another important injurious effect of endogenous and 
exogenous oxidants is peroxidation of lipids in cell 
membranes [14].  
  
The extent of ROS-induced DNA damage varies widely 
in different studies [1-6].
  According  to one  rather  con- 
 
 

































servative estimate, about 5,000 DNA single-strand 
lesions (SSLs) are generated per nucleus during a single 
cell cycle of approximately 24 h duration [6]. About 1% 
of those lesions become converted to DSBs, mostly 
during DNA replication. This leads to formation of ~50 
“endogenous DSBs”, the most severe and potentially 
mutagenic lesions [6]. DSBs can be repaired by two 
mechanisms, recombinatorial repair or nonhomologous 
DNA-end joining (NHEJ). The template-assisted 
recombinatorial repair is essentially error-free but takes 
place only when cells have already replicated their 
DNA which can serve as a template, namely in late-S 
and G2 phase of the cell cycle. DNA repair in cells 
lacking a template such as in G1 and early S phase 
occurs via the NHEJ mechanism. The latter is error-
prone and may result in deletion of some base pairs 
[15,16]. When such change occurs at the site of an 
oncogene or tumor suppressor gene it may promote 
carcinogenesis [17,18]. It can also lead to translocations 



























mitogenically stimulated  lymphocytes  or  tumor cell  lines  A549,  TK6  and  A431 to  metformin, the specific  activator of
5’AMP‐activated protein kinase (AMPK) and an inhibitor of mTOR signaling, resulted in attenuation of constitutive H2AX
phosphorylation  and  ATM  activation.  The  effects  were  metformin‐concentration  dependent  and  seen  even  at  the
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sequential cell cycle has been considered to be the 
primary cause of cell aging and senescence [20]. 
However, the notion that persistent stimulation of 
mTOR-driven pathways (rather than the ROS-induced 
DNA damage) is the major mechanism responsible for 
aging appears to have more merit [21-27]. Oxidative 
DNA damage, on the other hand, by contributing to 
replication stress may be a factor enhancing the TOR-
driven aging or senescence process [28].  
  
Strategies for preventing cancer or slowing down aging 
are often directed at protecting DNA from oxidative 
damage. Protective agents can be identified by their 
ability to reduce formation of “endogenous DSBs”. The 
direct detection of endogenous DSBs in individual cells 
has been difficult because the leading methodology, 
single cell electrophoresis (comet) assay [29], lacks the 
desired sensitivity. The TUNEL assay, developed to 
label DSBs in apoptotic cells, also lack sufficient 
sensitivity [30,31]. While the assays of DNA damage 
measurement in bulk offer greater sensitivity, these 
approaches do not allow one to relate the damage to 
individual cells, reveal any heterogeneity within cell 
populations, or the relationship of DSBs to cell cycle 
phase or apoptosis.  
  
Among the early and most sensitive reporters of DNA 
damage, and in particular formation of DSBs, is the 
activation of the Ataxia Telangiectasia mutated protein 
kinase (ATM) through its autophosphorylation on 
Ser1981 [32], and the phosphorylation of histone H2AX 
on Ser139; the phosphorylated H2AX is designated as 
γH2AX ]33]. Immunocytochemical detection of these 
events offers high sensitivity in assessment of DSBs 
formation in individual cells [34-37]. These biosensors 
of DNA damage have been used in conjunction with 
flow- or image-cytometry to assess DNA damage in 
cells exposed to a variety of exogenous genotoxins 
(reviews, [31,38]). In fact, the high sensitivity of these 
biomarkers makes it possible to use them to detect and 
measure the extent of constitutive DNA damage 
induced by the metabolically generated ROS in 
untreated cells [39-41]. Furthermore, these markers can 
be used to explore the effectiveness of factors protecting 
nuclear DNA from endogenous oxidants [42-45]. Thus, 
the anti-oxidants (N-acetyl-L-cysteine, ascorbate, 
Celecoxib), inhibitors of glycolysis and oxidative 
phosphorylation (2-deoxy-D-glucose and 5-bromo-
pyruvate), hypoxia (3-5% O2), confluency, low serum 
concentration, were all shown to distinctly reduce the 
level of constitutive ATM activation and H2AX 
phosphorylation [40-45]. Conversely, the factors 
enhancing metabolic activity (aerobic glycolysis) such 
as cell mitogenic activation, glucose, or dichloroacetate 
amplified the level of constitutive expression of γH2AX 
and activated ATM [42-45]. Collectively, these 
observations provide strong evidence that the extent of 
the ongoing DNA damage imposed by endogenous 
oxidants as well as the effectiveness of factors that 
protect from (or enhance) the damage can be assessed 
by analysis of the level of constitutive DNA damage 
signaling. 
  
In the present study we tested whether metformin, a 
drug widely prescribed to treat type 2 diabetes, has the 
ability to modulate the level of constitutive DNA 
damage signaling. Metformin is a specific activator of 
5’AMP-activated protein kinase (AMPK), a phylo-
genetically conserved serine/threonine kinase that plays 
a key role in cellular energy homeostasis (reviews, [46-
52]). AMPK is the energy sensor (”fuel gauge”) 
monitoring and regulating cellular energy in response to 
metabolic needs and nutritional environmental 
variations. This kinase is activated by low cellular 
energy status (increased AMP/ATP ratio) and responds 
by: (i) activating ATP-producing catabolic pathways 
such as glycolysis and fatty acids oxidation and (ii) 
suppressing the energy (ATP)-consuming anabolic 
pathways such as lipogenesis, gluconeogenesis and 
protein synthesis. Another effect of AMPK activation is 
inhibition of mammalian target of rapamycin (mTOR), 
the downstream effector of growth factor signaling 
pathways [51]. AMPK affects these activities by 
phosphorylating proteins regulating these pathways 
(instant effect) as well as by modulating transcription of 
genes encoding proteins of these pathways (delayed 
effect) [53-55]. AMPK itself is activated by the 
upstream mediator liver kinase B1 (LKB1) [52]. 
Activation of AMPK by metformin was shown to 
reduce intracellular reactive oxygen species (ROS) 
levels via upregulation of expression of the antioxidant 
thioredoxin through the AMPK-FOXO3 pathway [55]. 
 
There is a growing body of evidence that metformin 
may be considered a promising anti-aging candidate, 
applicable for life span extension, prevention and even 
treatment of cancer [22-27,50,56].  Given the above, it 
is of additional interest to know how metformin affects 
the level of constitutive DNA signaling in normal and 
tumor cells. Our present data show that in normal 
lymphocytes, as well as in cells of tumor lines the level 
of constitutive ATM activation and γH2AX expression 
was distinctly attenuated upon exposure to metformin. 




The effect of metformin was tested on the level of 
constitutive expression of γH2AX and Ser1981-
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A549 cells. The cells were grown attached on slides and 
the expression of these phospho-proteins was measured 
by laser scanning cytometry (LSC) [57]. The data 
provide clear evidence that expression of γH2AX in 
A549 cells growing in the presence of metformin for 48 h 
was reduced (Figure 1). The reduction was apparent at 1 
mM, and was progressively more pronounced following 















































Across all the three metformin concentrations, the degree 
of reduction in γH2AX expression was more distinct in 
G2M- and S- phase cells compared to cells in the G1-
phase of the cycle. The DNA content frequency 
histograms did not show major changes in the cell cycle 
distribution following 48 h treatment with up to 10 mM 
metformin, while only a modest decrease in the 
proportion of S-phase cells was apparent following 
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expression of ATM phosphorylated on Ser1981 in A549 
cells was strikingly similar to that of γH2AX (Figure 2). 
The degree of reduction of ATM-S1981
P was 
metformin-concentration dependent. While the decline 
in ATM activation was seen in all phases of the cell 
cycle, the most pronounced reduction was evident in S-
phase cells (Figure 2). 
 
In the next set of experiments we have tested the effect 
of metformin on human lymphoblastoid TK6 cells. 












































upon staining with phospho-specific Abs, was measured 
by flow cytometry [57]. The data show that, similar to 
A549, the expression of γH2AX was also reduced in 
TK6 cells exposed to metformin (Figure 3). The effect 
could be seen (7 – 10% decrease) even at a metformin 
concentration as low as 0.1 mM, and was more 
pronounced (up to 44% reduction) at higher 
concentrations. In TK6 cells the reduction in γH2AX 
was more pronounced in G1 and S phase than in G2M 
phase cells. The level of constitutively activated ATM 
was also decreased in TK6 cells growing in the 




















































































Figure 5 illustrates the effect of metformin on 
proliferating human lymphocytes. The peripheral blood 
lymphocytes were stimulated to proliferate by the 
polyvalent mitogen phytohemagglutinin for 48 h and 
subsequently were grown in the absence or presence of 
5 mM metformin for 24 h. The data show that, as was 
the case with the tumor cell lines A549 and TK6, 
growth of lymphocytes in the presence of 5mM 
metformin distinctly reduced both the level of 




As mentioned in the Introduction, the decline in the 
level of constitutive expression of γH2AX and 
phosphorylation of ATM was observed in cells treated 
with agents that decrease the level of endogenous 
oxidants such as ROS scavengers or antioxidants [39-
45,58]. Therefore, we assessed the effect of metformin 
on the abundance of reactive oxidants in human 
leukemic TK6 cells in the same cultures in which we 
observed the decline in expression of γH2AX (Figure 3) 
and ATM-S1981
P (Figure 4). As is quite evident from 
the data shown in Figure 6, the growth of TK6 cells for 
48 h in the presence of metformin led to a decrease in 
the level of ROS that were detected by their ability to 
oxidize 2',7'-dihydro-dichlorofluorescein diacetate 
(H2DCF-DA); following oxidation by ROS the non-
fluorescent substrate H2DCF-DA is converted to the 
highly fluorescent product DCF [59]. The effect was 
concentration dependent and the oxidation of H2DCF-
DA was reduced by nearly two orders of magnitude at a 
10 mM concentration of metformin compared to 















































The present data demonstrate that exposure of either 
normal, mitogenically activated lymphocytes, or tumor 
cell lines (A549, TK6) to metformin leads to a decrease 
in the level of constitutive phosphorylation of H2AX on 












Figure  6.  Effect  of  metformin  on  ability  of  TK6  cells  to
oxidize  2',7'‐dihydro‐dichlorofluorescein  diacetate
(H2DCF‐DA). TK6 cells were untreated (Ctrl) or treated with 1, 5
or  10  mM  metformin  (MF)  for  48  h.  The  cells  were  then
incubated  for  30  min  with  10 μ M  H2DCF‐DA  and  their
fluorescence was measured by flow cytometry. While H2DCF‐DA
is  not  fluorescent,  the  product  of  its  oxidation  (DCF)  by
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as low as 0.1 mM metformin (Figures 3 and 4). 
Pharmacokinetic data indicate that this concentration of 
metformin is of pharmacological relevance [60].
 Since 
the level of constitutive expression of γH2AX and 
ATM-S1981
P to a large extent reports DNA damage 
signaling in response to DNA damage by endogenous 
oxidants generated during aerobic respiration [39-
45,58]. the present findings would be consistent with a 
notion that metformin exerts protective effect on 
nuclear DNA against oxidative damage. These findings 
are consistent with the observation that exposure of 
cells to metformin lowered the extent of reactive 
oxidants that were able to oxidize the H2DCF-DA 
substrate (Figure 5). They are also in accordance with 
numerous studies in which a decrease in the level of 
ROS in cells treated with metformin has been observed 
[55,61-65].
  It appears that the mechanisms activated by 
metformin for neutralizing ROS such as upregulation of 
the antioxidant thioredoxin [55], and/or suppression of 
NAD(P)H oxidase activity [61] may prevail over the 
ROS-generating inhibitory effect on mitochondrial 
respiratory complex I or catabolic processes activated 
by AMPK [66,67]. 
 
It should be noted that DNA damage signaling such as 
reported by H2AX phosphorylation and ATM activation 
do not necessarily indicate the actual DNA damage that 
involves formation of DNA strand breaks [68]. While 
some breaks may be formed during replication of DNA 
sections containing the primary oxidative lesions (e.g. 
oxo8dG) the presence of such lesions by themselves can 
induce persistent replication stress. The persistent 
replication stress combined with activation of mTOR 
pathways is considered to be the main mechanism 
contributing to aging and senescence [22-27,69,70]. 
Induction of replication stress by arrest in the cell cycle 
e.g. by upregulation of the CKI p21, with no evidence 
of actual DNA damage, elevates the level of 
constitutive DNA damage signaling (“pseudo-DNA 
damage response”) whereas attenuation of this “pseudo-
DNA damage response” can be achieved by reduction 
in mTOR-signaling [29]. Likewise, the cell senescence 
induced by the replication stress triggered by low doses 
(1 – 2 nM) of the DNA damaging agent mitoxantrone, 
that is also accompanied by elevated levels of DNA 
damage signaling, was shown to be attenuated by the 
caloric restriction-mimicking drug 2-deoxy-D-glucose 
[71]. All this evidence collectively indicates that the 
observed constitutive DNA damage signaling occurs as 
a response to persistent DNA replication stress. Thus, 
by reducing the level of DNA damage signaling, as we 
presently see, metformin appears to alleviate the extent 
of the persistent DNA replication stress. Since 
metformin inhibits mTOR pathways, the reduction of 
replication stress by metformin may not only be 
mediated by attenuation of the oxidative stress through 
reduction of ROS, but also may be mediated by its 


























Our observation that cells exposure to metformin 
reduces expression of γH2AX and ATM-S1981
P 
remains in contrast to recent data by Vazquez-Martin et 
al., that show the opposite, namely an activation of 
ATM and phosphorylation of H2AX in cells treated 
with metformin [72]. This report prompted us to repeat 
our experiments numerous times, using a variety of 
positive and negative controls. Yet in each experiment 
we observed that treatment of proliferating 
lymphocytes, TK6 or A549 cells led to a decline in 
expression of γH2AX and ATM-S1981
P. We have also 
tested the A431 epidermoid carcinoma cells used by 
these authors [72]. The data show that treatment of 
A431with metformin decreased the level of H2AX and 
ATM phosphorylation (Supplemental data, Figure 1). 
To exclude the possibility of bias resulting from 
different methodologies we also assessed the effect of 
metformin on expression of γH2AX and ATM-S1981
P 
in TK6 cells using immonoblotting, the methodology 
used by the authors [72]. The results obtained by 
immunobloting (Figure 7) confirm all our 
immunocytochemical data (Figs. 1-5) by showing a 
distinct reduction of γH2AX and ATM-S1981
P in cells 
treated with metformin. In fact, the reduction in 
expression of ATM-S1981
P was nearly 45% related to 
the control. We have also observed that constitutive 
Figure 7. Detection of γH2AX and ATM‐S1981
P in TK6
cells  untreated  (Ctrl)  and  treated  with  5  mM






www.impactaging.com                  1033                                     AGING, October 2011, Vol.3 No.10H2AX phosphorylation and ATM activation in 
quiescent A549 cells, maintained for 5 days at high cells 
density (>10
6 cells/ml) with no medium change also 
was reduced by treatment with metformin 
(Supplemental data Figure 2). The effect of metformin, 
thus, was unrelated as to whether the cells were in 
exponential- or stationary- phase of growth. Our data 
also concur with the findings of Nilsson et al., who did 
not detect any induction of γH2AX in U2OS or HT1080 
cells treated with 40 mM metformin [73]. Actually, 
careful inspection of their data provides some evidence 
of a decline in expression of γH2AX upon treatment 
with metformin [73]. At present we see no explanation 
for the apparent discrepancy of our results (and the data 
of Nilsson et al., [73]) versus the data presented by 
Vazquez-Martin al., [72]. 
 
As mentioned, cell aging and senescence appear to be 
driven by persistent mTOR activation in conjunction 
with DNA replication stress; the latter can be induced 
by ROS as well as by inhibition of cell cycle 
progression, such as activation of CKIs. DNA 
replication stress and mTOR activation are being 
reported by the elevated level of constitutive DNA 
damage signaling (“pseudo-DNA damage response”) 
[29,71]. 
 As shown in the present study, the effective-
ness of potential anti-aging factors such as metformin 
may be tested by monitoring their effect on constitutive 
DNA damage signaling. This approach offers novel 
means to assess the anti-aging or aging-promoting 
properties of different factors suspected of such 
activities. Assessment of DNA damage signaling may 
serve to detect both genotoxicity [38,74] as well as 
genome-protective mechanisms related to attenuation of 
DNA replication stress.  
 
MATERIALS AND METHODS 
 
Cells, cell treatment.  Human lung carcinoma A549 
cells, epidermoid carcinoma A431 and lymphoblastoid 
TK6 cells were obtained from American Type Culture 
Collection (ATCC CCL-185, Manassas,VA). Human 
peripheral blood lymphocytes were obtained by 
venipuncture from healthy volunteers and isolated by 
density gradient centrifugation. A549 cells were 
cultured in Ham’s F12K, TK6 and lymphocytes were 
cultured in RPMI 1640 and A431cells in Dulbecco 
modified Eagle medium, with 2 mM L-glutamine 
adjusted to contain 1.5 g/L sodium bicarbonate 
supplemented with 10% fetal bovine serum 
(GIBCO/Invitrogen, Carlsbad, CA). Adherent A549 and 
A431 cells were grown in dual-chambered slides (Nunc 
Lab-Tek II), seeded with 10
5 cells/ml suspended in 2 ml 
medium per chamber. TK6 cells and lymphocytes were 
grown in suspension; lymphocyte cultures were treated 
with the polyvalent mitogen phytohemaglutinin (Sigma 
/Aldrich; St Louis, MO) as described [75]. During 
treatment with metformin  (1,1-dimethylbiguanide; 
Calbiochem, La Jolla, CA) the cells were in exponential 
phase of growth unless indicated otherwise. After 
exposure to metformin at various concentrations and for 
specified periods of time (as shown in figure legends) 
the cells were rinsed with phosphate buffered salt 
solution (PBS) and fixed in 1% methanol-free 
formaldehyde (Polysciences, Warrington, PA) for 15 
min on ice The cells were then transferred to 70% 
ethanol and stored at -20 
oC for up to 3 days until 
staining. 
 
Detection of H2AX phosphorylation and ATM 
activation.  The cells were washed twice in PBS and 
with 0.1% Triton X-100 (Sigma) in PBS for 15 min and 
with a 1% (w/v) solution of bovine serum albumin 
(BSA; Sigma) in PBS for 30 min to suppress 
nonspecific antibody (Ab) binding. The cells were then 
incubated in 1% BSA containing a 1:300 dilution of 
phospho-specific (Ser139) γH2AX mAb (Biolegend, 
San Diego, CA or with a 1:100 dilution of phospho-
specific (Ser1981) ATM mAb (Millipore, Tamecula, 
CA).  The secondary Ab was tagged with AlexaFluor 
488 fluorochrome (Invitrogen/Molecular Probes, used at 
1:200 dilution). Cellular DNA was counterstained with 
2.8  μg/ml 4,6-diamidino-2-phenylindole (DAPI; 
Sigma). Each experiment was performed with an IgG 
control in which cells were labeled only with the 
secondary AlexaFluor 488 Ab, without primary Ab 
incubation to estimate the extent of nonspecific 
adherence of the secondary Ab to the cells. The 
fixation, rinsing and labeling of A549 or A431 cell was 
carried out on slides, and lymphocytes and TK6 cells in 
suspension. Other details have been previously 
described [38-40].  
 
Analysis of cellular fluorescence. A549 and A431 cells: 
Cellular immunofluorescence  representing the binding 
of the respective phospho-specific Abs as well as the 
blue emission of DAPI stained DNA was measured with 
an LSC (iCys; CompuCyte, Westwood, MA) utilizing 
standard filter settings; fluorescence was excited with 
488-nm argon, helium-neon (633 nm) and violet (405 
nm) lasers [76]. The intensities of maximal pixel and 
integrated fluorescence were measured and recorded for 
each cell. At least 3,000 cells were measured per 
sample. Gating analysis was carried out as described in 
Figure legends. TK6 cells and lymphocytes:  C e l lu la r  
fluorescence was measured by using a MoFlo XDP 
(Beckman-Coulter, Brea, CA) high speed flow 
cytometer/sorter. DAPI fluorescence was excited with 
the UV laser (355-nm) and AlexaFluor 488 with the 
argon ion (488-nm) laser. 
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blocked with 5% w/v nonfat dry milk in TBST (20 mM 
TrisHCl, pH 7.4, 150 mM NaCl, 0.05% Tween 20) for 
1h at room temperature. The blot was then incubated 
with the primary antibody either phospho-specific 
(Ser139)  γH2AX mAb (Biolegend) or a phospho-
specific (Ser1981) ATM mAb (Millipore) at 1:500 
dilution overnight at 4 °C. After three washes in TBST, 
the blot was incubated with HRP-conjugated goat anti-
mouse IgG (Pierce, Rockford, IL) for 1h at room 
temperature and washed with TBST three times. 
SuperSignal West Pico chemiluminescence substrate 
(Pierce) was used for signal production.   
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Supplemental Figure 2. Effect of metformin (MF) on the level of expression of γH2AX 
in TK6 cells in stationary cultures. TK6 cells were maintained at high cell density (>10
6
cells/ml) with no medium change for 5 days, then cells were left untreated  (Ctrl) or treated with
5 mM metformin for 24 h (MF) . The percent decline in mean values of γH2AX IF of cells in G1, S, 
and G2M phases of the cycle in the metformin‐treated culture is shown in the MF panel.  
 